TrialPediatric blood & cancer2018

Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis.

Sara Zarnegar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.